Decoding Pleural Mesothelioma: Insights from a Ten-Year Study
Recently, a group of researchers studied 169 patients with pleural mesothelioma over ten years. They wanted to gain a deeper…
The Future of Mesothelioma Diagnosis: A Faster, More Affordable Solution
A new study’s groundbreaking findings show that using both MTAP and p16 IHC can be a powerful tool in diagnosing…
Paradigm Shift in Mesothelioma Treatment: Targeting PD-1 Biomarker for Improved Outcomes
A recent study in mesothelioma patients opens a new chapter in the fight against this challenging disease. It enhances our…
Meet FLT PET: A New Hope for Mesothelioma Patients
There’s a new tool called F18-Fluorothymidine (FLT) PET. It takes pictures inside the body and focuses on how the cancer…
Cracking the Code: SPARC, the New Mesothelioma Diagnostic Marker
Scientists from Japan have found a new mesothelioma marker called SPARC that could help doctors diagnose this rare cancer. This…
Immunotherapy’s Impact on the Mesothelioma Immune System
The battle against mesothelioma has seen significant developments in recent years. Many developments are with the introduction of immunotherapy as…
Battling Mesothelioma: How PICC Devices Make a Difference in Patients’ Lives
Mesothelioma, a rare and aggressive cancer, often takes a silent toll on the lives of those affected. This disease, linked…
The Persistence of Mesothelioma in a Post-Asbestos Era
Mesothelioma is a type of cancer caused by exposure to a harmful mineral called asbestos. It takes decades for mesothelioma…
MTH1 Protein: A New Ally in the Fight Against Mesothelioma
Scientists are now investigating a protein known as MTH1. They are delving into its role in boosting the body’s immune…
Evening Primrose Extract: Targeting TYMS for Mesothelioma Treatment
Recent studies have provided exciting insights into how evening primrose extract interacts with TYMS. TYMS is a protein crucial in…